↓ Skip to main content

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Published in
Journal for Immunotherapy of Cancer, October 2019
DOI 10.1186/s40425-019-0758-y
Pubmed ID
Authors

Wendy Mao, Ali Ghasemzadeh, Zachary T. Freeman, Aleksandar Obradovic, Matthew G. Chaimowitz, Thomas R. Nirschl, Emily McKiernan, Srinivasan Yegnasubramanian, Charles G. Drake

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 18%
Student > Master 6 18%
Researcher 6 18%
Student > Bachelor 5 15%
Librarian 1 3%
Other 3 9%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 7 21%
Biochemistry, Genetics and Molecular Biology 6 18%
Nursing and Health Professions 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Chemistry 2 6%
Other 4 12%
Unknown 9 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2019.
All research outputs
#5,893,844
of 18,943,833 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,101
of 2,043 outputs
Outputs of similar age
#131,572
of 340,518 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#232
of 344 outputs
Altmetric has tracked 18,943,833 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,518 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.